Weiss Asset Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Weiss Asset Management LP
CRD #155564
SEC #801-73590
CIK #0001357550
AUM 15.56 B (2026-03-20)
Employees 139 (46% Investors, 0% Brokers)
Fees
Minimum
Phone617-778-7780
Address222 Berkeley Street
Boston, MA 02116
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
2016128402010201520212027
Fees and Compensation — Form ADV Part 2A (3/20/2026) [Brochure]
Item 5.        Fees and Compensation

In consideration for the investment management services that Weiss provides to the Funds, Weiss and its
affiliates receive fees and other compensation from the Funds. This compensation generally takes the form of
an asset-based management fee (the “Management Fee”) and/or performance-based compensation that is
dependent on the investment performance of the portfolio under management for the relevant Fund (the
“Performance-Based Compensation”), each paid to Weiss in accordance with its Investment Management
Agreement with the relevant Fund.

The Funds generally offer investors the opportunity to subscribe for two different types of shares (in the
context of the Cayman Fund) or interests (in the context of the U.S. Fund). These two different types of
investments that investors may make in the Funds are referred to as (1) “Funded Shares” or “Funded Interests,”
and (2) “Commitment Shares” or “Commitment Interests,” as applicable. Funded Shares and Funded Interests
are paid for by the investor up-front and participate in the gains and losses of the relevant Fund as of their
subscription date. Commitment Shares and Commitment Interests, by contrast, are unfunded upon issuance
and represent a commitment by the Investor to fund a certain amount (the “Conversion Amount,” as such term
is defined in the applicable offering memorandum) at a later date, upon the receipt of notice from the applicable
Fund. Investors that make aggregate subscriptions for Funded Shares and/or Funded Interests over a certain
threshold specified in the respective offering memoranda of the Funds have the option to irrevocably elect for
all of their Funded Shares and/or Funded Interests to be considered “Institutional Shares” or “Institutional
Interests”, as applicable. With respect to Funded Shares and Funded Interests that are not Institutional Shares
or Institutional Interests, a Management Fee is payable quarterly in arrears, in an amount generally equal to
0.125% (approximately 0.5% annualized) of the net asset value of (i) each series of shares in the context of
the Cayman Fund, and (ii) each limited partner’s capital account in the context of the U.S. Fund, in each case
as computed at the end of each quarter (before deducting the Performance-Based Compensation, as defined
below), and is subject to modification for any particular investor as may be negotiated between the relevant
Fund and the particular investor. No Management Fee is charged in respect of any Commitment Shares or
Commitment Interests, or in respect of any Institutional Shares or Institutional Interests. Additionally, an
investor in a Fund who subscribes for new Funded Interests or Funded Shares or converts Commitment Shares
or Commitment Interests into Funded Shares or Funded Interests (by contributing the applicable Conversion
Amounts) other than on the first day of a calendar quarter, or who withdraws from or redeems (as applicable)
other than on the last day of a calendar quarter (and, in each case, who does not elect for such Funded Shares
or Funded Interests to be considered Institutional Shares or Institutional Interests, as applicable) will be subject
to a pro rata portion of the Management Fee paid for such quarter based upon the portion of the calendar
quarter for which such Funded Shares or Funded Interests were outstanding in such Fund. The Management
Fee is paid by the Funds to Weiss after the conclusion of each calendar quarter.

In addition, Weiss or an affiliated entity receives Performance-Based Compensation from each Fund.
Generally, at the end of each fiscal year (or other period when a calculation of performance compensation is
required), each Fund will pay (or allocate) to Weiss or the U.S. Fund General Partner, as applicable,
Performance-Based Compensation in an amount generally equal to 20% of the aggregate net profits during
such fiscal year that (i) for the Cayman Fund are attributable to each series of Funded Shares and (ii) for the
U.S. Fund are attributable to each capital account maintained for a limited partner in respect of any Funded
Interests, subject in each case to a high watermark and as may otherwise be negotiated between the relevant
Fund and any particular investor. No Performance-Based Compensation is paid or allocated, as applicable, in
respect of any Commitment Shares or Commitment Interests. Net profits and net losses are calculated for a
period by combining the aggregate net realized and unrealized changes in the value of each Fund’s assets with
all other items of income and expenses of any kind for such period. In the event that any series of shares or
any capital account of a limited partner has unrecovered net losses from any prior relevant accounting period,
Weiss or the U.S. Fund General Partner, as the case may be, will not be paid or allocated Performance-Based

Compensation with respect to such series of shares or capital account until such net losses have been recovered
(which net losses are proportionately reduced by any redemptions or withdrawals from such series of shares
or capital account, respectively). In the event of a redemption or withdrawal by an investor in a Fund on any
date other than the last day of a fiscal year, the Performance-Based Compensation in respect of the amount
redeemed or withdrawn will be computed as of the date of such redemption or withdrawal. Unrealized
appreciation and depreciation relating to investments segregated by a Fund as “Designated Investments”
because they may be illiquid or difficult to value would generally not be allocated to a shareholder’s series of
shares or a limited partner’s capital account, as applicable, for purposes of determining the Performance-Based
Compensation until such Designated Investment is sold or the relevant Fund otherwise determines that it
should no longer be treated as a Designated Investment.
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/20/2026) [Brochure]
Item 7.       Types of Clients

As noted in Item 4, Weiss is an investment adviser to two pooled investment vehicles, the Funds, which are
privately offered open-end hedge funds. The Funds are exempt from registration as investment companies
under the Investment Company Act and are not publicly offered in any jurisdiction.

At the time an investor makes an investment, each investor in the U.S. Fund and each U.S. investor in the
Cayman Fund, must be (i) both an “accredited investor,” as defined in Regulation D under the Securities Act
of 1933, as amended (the “Securities Act”) and a “qualified purchaser,” as that term is defined in Section
2(a)(51) of the Investment Company Act, or (ii) a “knowledgeable employee” as that term is defined in Rule
3c-5 of the Investment Company Act. Prior to April 1, 2019, the Funds relied on the exclusion from the
definition of investment company in Section 3(c)(1) under the Investment Company Act; since that date, the
Funds have instead relied on the exclusion in Section 3(c)(7). The U.S. Fund does not impose a minimum
capital commitment for any investor. The minimum initial investment in the Cayman Fund is $50,000, or such
other minimum amount as specified from time to time by the relevant authorities in the Cayman Islands.

Weiss may serve as investment manager for additional funds, special purpose vehicles or separate accounts in
the future (“Other Accounts”).
Sector Form 13F Holdings Value ($B)
Nvidia Corp 1.2
MicroStrategy Inc 0.2
Sprott Physical Silver Trust 0.2
Theravance Biopharma Inc 0.1
iShares Bitcoin Trust 0.1
Sandy Springs Holdings Inc 0.1
Sprott Physical Gold & Silver Trust 0.1
Tesla Motors Inc 0.0
PPL Corp 0.0
Super Micro Computer Inc 0.0
View All
Holdings by Sector ($B)
10.08.06.04.02.00.02011201620212027
Type Form D Funds Date Sold AUM
HF SPAC Opportunity Fund II [2022-03-01] 205.0 M 565.0 M
Filed 2022-09-30 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Cape May Investments LP [2017-03-29] 369.3 M 0.2 M
Filed 2022-04-01 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Weiss Korea Opportunity Fund Ltd [2013-08-08] 40.5 M 122.0 M
Offered $40,493,821 · Filed 2013-05-29 (D) · Exemption 506, 3(c), 3(c)(7) · Duration One year or less · Commission $427,228 · Net Assets Decline to Disclose
HF Brookdale Global Opportunity Fund [2012-02-14] 1,825.9 M 8,329.9 M
Filed 2025-04-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Brookdale International Partners LP [2012-02-14] 2,027.6 M 7,227.5 M
Filed 2025-04-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 2 15.6
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 2 15.6
By Discretionary
Discretionary 2 15.6
Non-Discretionary 0 0.0
Total 2 15.6
By Non-United States Persons
Non-United States Persons 8.3
United States Persons 7.2
Total 2 15.6
Form D Directors Role # Filings # Firms 2011 - 2026
Peter Young Director 116 22
Jonathan Morgan Director 50 12
Robert King Director 60 5
Andrew Weiss Executive Officer, Promoter 18 2
Stephen Coe Director 2 2
Weiss Asset Management LP Executive Officer, Promoter 4 1
Paul Sherman Executive Officer 4 1
Daniel Fu Executive Officer 4 1
Eitan Milgram Executive Officer 3 1
Aep LLC Director 2 1
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001357550]
3 [0001357550]
4 [0001357550]
SC 13D [0001357550]
SC 13G [0001357550]
Form 13D/13G Filer Form 13D/13G Subject Filed
Weiss Asset Management LP Empery Digital Inc [2026-05-11]
Weiss Asset Management LP Apartment Investment & Management Co [2026-05-11]
Weiss Asset Management LP New America Acquisition I Corp [2026-02-17]
Weiss Asset Management LP Semler Scientific Inc [2026-02-11]
Weiss Asset Management LP Canaan Inc [2026-02-11]
Weiss Asset Management LP Bakkt Holdings Inc [2025-11-12]
Weiss Asset Management LP Site Centers Corp [2025-11-12]
Weiss Asset Management LP scPharmaceuticals Inc [2025-11-12]
Weiss Asset Management LP Equity Commonwealth [2024-10-31]
Weiss Asset Management LP Theravance Biopharma Inc [2023-04-12]
View All
Firm Profile (Form ADV)
Discretionary AUM$1.8B
ServesInstitutional
Fund TypesHedge Fund
LEIIT8LF3P4X72T709F5Z71
Form 3/4/5 Subject 2011 - 2026
Avadel Pharmaceuticals PLC
Weiss Andrew M
Weiss Asset Management LP
Theravance Biopharma Inc
WAM GP LLC
BIP GP LLC
Thunder Bridge Capital Partners IV Inc
Enjoy Technology Inc/DE
Pfenex Inc
ETHZilla Corp
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Avadel Pharmaceuticals PLC AVDL
Ordinary Shares
2026-02-13 Sell 11,112,052 $21.00 233,353,092
Enjoy Technology Inc/DE MRAC
Class A Ordinary Shares
2021-05-14 Sell 150,000 $9.86 1,479,000
Pfenex Inc PFNX
Common Stock
2020-09-30 Tender 801,424 $12.00 9,617,088
Pfenex Inc PFNX
Common Stock
2020-09-29 Sell 100,000 $12.74 1,274,000
ETHZilla Corp KBLM
Common Stock, par value $0.0001 per share
2019-06-05 Other 310,000 $10.42 3,230,200
Atlantic Alliance Partnership Corp AAPC
Ordinary Shares
2016-11-03 Other 1,225,100 $10.52 12,888,052
Rosehill Resources Inc KLRE
Class A common stock
2016-07-01 Sell 10,000 $10.00 100,000
Walker Innovation Inc GLOI
Common Stock
2012-03-26 Sell 1,385,529 $3.05 4,225,863
Comparable Firms State AUM
Compass Rose Asset Management LP
NY 16.50 B
Freestone Grove Partners LP
CA 16.48 B
RA Capital Management LP
MA 16.40 B
O'Connor Alternative Investments LLC
NY 16.37 B
Varde Management LP
NY 16.13 B
Whitebox Advisors LLC
MN 15.74 B
Soroban Capital Partners LP
NY 15.67 B
Intech Investment Management LLC
FL 15.47 B
Wolverine Asset Management LLC
IL 14.83 B
Pharo Management Inc
NY 14.62 B
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com